Press Release: Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Retrieved on:
Thursday, February 22, 2024
Senior, Audit, Compass Group, Immunology, Clotilde Delbos, Emlyon Business School, Henley Business School, Nomination, Duke, Axa, Bucknell University, Interim, Specialization, Therapy, Biology, Committee, Childhood arthritis, RCI Banque, Pechiney, Pandion, GSK plc, PwC, Division, Lonrho, Gilead Sciences, Merlin, Corporate responsibility, Audit committee, Business administration, Duke University, Immune tolerance, Science, Annual, Management
Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Key Points:
- Sanofi’s Board of Directors proposes the appointment of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy as independent Directors
Paris, February 22, 2024. - The Chairman warmly thanked them for their valued contribution to the Board of Directors and the specialized committees to which they belonged during their terms in office.
- In 2016, Clotilde Delbos was appointed Group Chief Financial Officer and Chairman of Board of Directors of RCI Banque.
- “The arrivals of Clotilde Delbos, Anne-Françoise Nesmes and John Sundy will strengthen the Board of Directors’ expertise in finance and science, notably in the field of immunology.